$2.570
-0.059 (-2.28%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CRVO por análisis de gráficos similares
Alphio's CRVO stock price prediction model matches the current CervoMed Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.60 (+0.99%). The 1-week path is $2.54 (-1.04%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de CervoMed Inc?
CervoMed Inc is not a good buy right now due to its current price of $2.60, which is significantly below the analyst price target of $7 from Roth Capital. Additionally, the stock has a low RSI of 37.007, indicating it is nearing oversold conditions, but the overall trend remains negative with a year-to-date change of -66.62%. The main risk is the company's ongoing financial losses, with a net income of -6,571,656 USD reported for Q2 2026, which raises concerns about its sustainability and ability to fund future trials.
CRVO cerró en $2.57 el Tuesday, tras bajar -2.28%
CervoMed Inc (CRVO) last closed at $2.57, losing -2.28%. These facts feed the 1-day and 1-week CRVO price prediction above.
Factores de la previsión
Los factores de la previsión de CervoMed Inc (CRVO) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CRVO, ordenadas por similitud.
Análisis de estacionalidad de CRVO
Historically the probability of a positive September return for CRVO is 97.62%. October offers the highest probability of a positive month at 100.00%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.